Table 2 Baseline characteristics of HCV cirrhotic patients (n = 44).
Variable | No. of patients |
|---|---|
Gender | |
Male | 25 (57%) |
Female | 19 (43%) |
Age | |
Mean ± SD | 49.8 ± 12.33 |
Range | 23–81 |
Cirrhosis stage | |
Mild | 27 (61%) |
Moderate | 10 (23%) |
Gross | 07 (16%) |
Treatment | |
Antiviral drugs | Sofusbuvir + ribavirin/daclatasvir |
ALT | |
Mean ± SD | 105.87 ± 30.77 |
Range | 87–283 |
AFP | |
Mean ± SD | 48.3 ± 39.80 |
Range | 34–279 |
Albumin | |
Mean ± SD | 3.7 ± 0.4 |
Bilirubin | |
Mean ± SD | 1.4 ± 0.8 |
AST | |
Mean ± SD | 41.3 ± 29.60 |
Range | 67- 209 |
Viral load | |
< 200,0000 IU/mL | 30 |
> 200,0000 IU/mL | 14 |
